Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx has reported Return on Sales over the past 7 years, most recently at 0.01% for Q3 2025.

  • Quarterly Return on Sales changed 0.0% to 0.01% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Sep 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2024, 0.0% changed from the prior year.
  • Return on Sales was 0.01% for Q3 2025 at Pulmonx, down from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q4 2024 and troughed at 0.01% in Q1 2022.
  • The 5-year median for Return on Sales is 0.01% (2023), against an average of 0.01%.
  • The largest YoY upside for Return on Sales was 2bps in 2021 against a maximum downside of -1bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then increased by 2bps to 0.01% in 2022, then rose by 22bps to 0.01% in 2023, then increased by 23bps to 0.01% in 2024, then fell by -17bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Sales are 0.01% (Q3 2025), 0.01% (Q2 2025), and 0.01% (Q1 2025).